focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,978.00
Bid: 1,983.00
Ask: 1,984.00
Change: -5.00 (-0.25%)
Spread: 1.00 (0.05%)
Open: 1,983.00
High: 1,991.00
Low: 1,971.00
Prev. Close: 1,983.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: S&P And Shore Upgrade Aviva After Strong Half

Fri, 05th Aug 2016 08:31

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning and Thursday:
----------
FTSE 100
----------
DEUTSCHE BANK RAISES RANDGOLD RESOURCES TARGET TO 7370 (7100) PENCE - 'HOLD'
----------
GOLDMAN CUTS SHELL B PRICE TARGET TO 2230 (2250) PENCE - 'CONVICTION BUY LIST'
----------
INDEPENDENT RESEARCH RAISES ANGLO AMERICAN TARGET TO 910 (840) PENCE - 'HOLD'
----------
JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 1770 (1760) PENCE - 'BUY'
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS TARGET TO 2955 (2400) P - 'EQUAL WEIGHT'
----------
JEFFERIES CUTS WOLSELEY TO 'HOLD' ('BUY') - TARGET 4180 (3980) PENCE
----------
SOCGEN CUTS NEXT PRICE TARGET TO 5695 (7133) PENCE - 'HOLD'
----------
JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 8300 (6800) PENCE - 'BUY'
----------
S&P GLOBAL CUTS HIKMA PHARMACEUTICAL TO 'HOLD' ('BUY') - TARGET 2400 PENCE
----------
UBS RAISES RSA INSURANCE PRICE TARGET TO 496 (456) PENCE - 'NEUTRAL'
----------
S&P GLOBAL RAISES AVIVA TO 'BUY' ('HOLD') - TARGET 450 (500) PENCE
----------
Shore Capital Upgrades Aviva To Hold From Sell
----------
UBS RAISES OLD MUTUAL PRICE TARGET TO 230 (210) PENCE - 'BUY'
----------
S&P GLOBAL RAISES STANDARD CHARTERED TO 'HOLD' (SELL) - PRICE TARGET 650 (480) PENCE
----------
UBS CUTS BT GROUP PRICE TARGET TO 425 (450) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
Numis Ups Tullow Oil To Hold From Reduce, Target To 200p From 190p
----------
Numis Ups Cairn Energy To Add From Hold, Keeps Target At 210p
----------
UBS RAISES CAIRN ENERGY TO 'BUY' ('NEUTRAL') - TARGET 220 PENCE
----------
S&P GLOBAL RAISES AGGREKO PRICE TARGET TO 950 (900) PENCE - 'SELL'
----------
PANMURE RESUMES RPC GROUP WITH 'BUY' - TARGET 1156 PENCE
----------
DEUTSCHE BANK CUTS COBHAM PRICE TARGET TO 150 (154) PENCE - 'HOLD'
----------
JEFFERIES RAISES HOWDEN JOINERY GROUP PRICE TARGET TO 430 (400) PENCE - 'HOLD'
----------
JEFFERIES RAISES GRAFTON GROUP PRICE TARGET TO 680 (620) PENCE - 'BUY'
----------
S&P GLOBAL CUTS SERCO GROUP TO 'HOLD' ('BUY') - TARGET 140 (115) PENCE
----------
MAIN MARKET AND AIM
----------
Numis Resumes Hornby At Buy, Price Target At 38p
----------
Investec Cuts Nichols To Hold From Buy, Ups Target To 1,472p From 1,450p
----------
Liberum Ups IFG Group Target To 220p From 215p, Keeps Buy
----------
UBS RAISES SOCO INTERNATIONAL PRICE TARGET TO 160 (145) PENCE - 'NEUTRAL'
----------
UBS RAISES PETRA DIAMONDS PRICE TARGET TO 150 (140) PENCE - 'BUY'
----------
By Lucy Heming; lucyheming@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.